JP2016515815A5 - - Google Patents

Download PDF

Info

Publication number
JP2016515815A5
JP2016515815A5 JP2016502986A JP2016502986A JP2016515815A5 JP 2016515815 A5 JP2016515815 A5 JP 2016515815A5 JP 2016502986 A JP2016502986 A JP 2016502986A JP 2016502986 A JP2016502986 A JP 2016502986A JP 2016515815 A5 JP2016515815 A5 JP 2016515815A5
Authority
JP
Japan
Prior art keywords
lipid
nucleic acid
alkyl
composition according
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502986A
Other languages
English (en)
Japanese (ja)
Other versions
JP6605446B2 (ja
JP2016515815A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/029116 external-priority patent/WO2014172045A1/en
Publication of JP2016515815A publication Critical patent/JP2016515815A/ja
Publication of JP2016515815A5 publication Critical patent/JP2016515815A5/ja
Application granted granted Critical
Publication of JP6605446B2 publication Critical patent/JP6605446B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502986A 2013-03-15 2014-03-14 形質移入用の脂質ナノ粒子および関連方法 Active JP6605446B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798495P 2013-03-15 2013-03-15
US61/798,495 2013-03-15
PCT/US2014/029116 WO2014172045A1 (en) 2013-03-15 2014-03-14 Lipid nanoparticles for transfection and related methods

Publications (3)

Publication Number Publication Date
JP2016515815A JP2016515815A (ja) 2016-06-02
JP2016515815A5 true JP2016515815A5 (https=) 2017-04-06
JP6605446B2 JP6605446B2 (ja) 2019-11-13

Family

ID=51731753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016502986A Active JP6605446B2 (ja) 2013-03-15 2014-03-14 形質移入用の脂質ナノ粒子および関連方法

Country Status (6)

Country Link
US (2) US10342760B2 (https=)
EP (1) EP2971013B1 (https=)
JP (1) JP6605446B2 (https=)
CN (1) CN105143456A (https=)
CA (1) CA2906732C (https=)
WO (1) WO2014172045A1 (https=)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3052521A1 (en) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
PL4023249T3 (pl) 2014-04-23 2025-03-10 Modernatx, Inc. Szczepionki z kwasem nukleinowym
CN106794141B (zh) * 2014-07-16 2021-05-28 诺华股份有限公司 将核酸包封在脂质纳米粒主体中的方法
WO2016138175A1 (en) * 2015-02-24 2016-09-01 The University Of British Columbia Continuous flow microfluidic system
EP4353257A3 (en) 2015-04-13 2024-08-07 CureVac Manufacturing GmbH Method for producing rna compositions
EP3288671A4 (en) * 2015-04-28 2019-01-16 The University Of British Columbia DISPOSABLE MICROFLUIDIC CARTRIDGE
USD772427S1 (en) 2015-04-28 2016-11-22 University Of British Columbia Microfluidic cartridge
USD771834S1 (en) 2015-04-28 2016-11-15 University Of British Columbia Microfluidic cartridge
USD771833S1 (en) 2015-04-28 2016-11-15 University Of British Columbia Microfluidic cartridge
MA42543A (fr) 2015-07-30 2018-06-06 Modernatx Inc Arn épitope peptidiques concatémériques
JP6948313B6 (ja) 2015-09-17 2022-01-14 モデルナティエックス インコーポレイテッド 治療剤の細胞内送達のための化合物および組成物
AU2016342045A1 (en) 2015-10-22 2018-06-07 Modernatx, Inc. Human cytomegalovirus vaccine
EP4011451A1 (en) 2015-10-22 2022-06-15 ModernaTX, Inc. Metapneumovirus mrna vaccines
WO2017070624A1 (en) 2015-10-22 2017-04-27 Modernatx, Inc. Tropical disease vaccines
AU2016341309A1 (en) 2015-10-22 2018-06-07 Modernatx, Inc. Cancer vaccines
PL3386484T3 (pl) * 2015-12-10 2022-07-25 Modernatx, Inc. Kompozycje i sposoby dostarczania środków terapeutycznych
LT3394030T (lt) 2015-12-22 2022-04-11 Modernatx, Inc. Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu
EP3400097B1 (en) 2016-01-06 2021-01-27 The University Of British Columbia Bifurcating mixers and methods of their use and manufacture
CN105622473B (zh) * 2016-02-06 2017-07-25 吴国球 一种阳离子氨基脂质及其合成方法和用途
WO2017201328A1 (en) 2016-05-18 2017-11-23 Modernatx, Inc. POLYNUCLEOTIDES ENCODING α-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE
WO2017218704A1 (en) 2016-06-14 2017-12-21 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
KR102447457B1 (ko) 2016-07-06 2022-09-27 프레시젼 나노시스템스 유엘씨 지능형 미세 유체 혼합 기기 및 카트리지
WO2018064755A1 (en) * 2016-10-03 2018-04-12 Precision Nanosystems Inc. Compositions for transfecting resistant cell types
EP3528821A4 (en) 2016-10-21 2020-07-01 ModernaTX, Inc. HUMAN CYTOMEGALOVIRUS VACCINE
US11583504B2 (en) 2016-11-08 2023-02-21 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
MA46766A (fr) 2016-11-11 2019-09-18 Modernatx Inc Vaccin antigrippal
WO2018170322A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Crystal forms of amino lipids
CA3055653A1 (en) * 2017-03-15 2018-09-20 Modernatx, Inc. Lipid nanoparticle formulation
EP3595713A4 (en) 2017-03-15 2021-01-13 ModernaTX, Inc. RESPIRATORY SYNCYTIAL VIRUS Vaccine
EP4186888B1 (en) 2017-03-15 2025-11-26 ModernaTX, Inc. Compound and compositions for intracellular delivery of therapeutic agents
US11905525B2 (en) 2017-04-05 2024-02-20 Modernatx, Inc. Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins
WO2018232120A1 (en) 2017-06-14 2018-12-20 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
MA49421A (fr) 2017-06-15 2020-04-22 Modernatx Inc Formulations d'arn
CN107488137B (zh) * 2017-08-15 2019-03-29 浙江大学 一种小分子量的季铵盐及其制备方法和应用
EP3675817A1 (en) 2017-08-31 2020-07-08 Modernatx, Inc. Methods of making lipid nanoparticles
US20230140670A1 (en) * 2017-09-29 2023-05-04 Intellia Therapeutics, Inc. Formulations
EP3746090A4 (en) 2018-01-29 2021-11-17 ModernaTX, Inc. RSV RNA Vaccines
US11679159B2 (en) 2018-04-29 2023-06-20 Precision NanoSystems ULC Compositions for transfecting resistant cell types
WO2020061295A1 (en) * 2018-09-19 2020-03-26 Modernatx, Inc. High-purity peg lipids and uses thereof
CA3113025A1 (en) 2018-09-19 2020-03-26 Modernatx, Inc. Peg lipids and uses thereof
WO2020061367A1 (en) 2018-09-19 2020-03-26 Modernatx, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
WO2020061457A1 (en) 2018-09-20 2020-03-26 Modernatx, Inc. Preparation of lipid nanoparticles and methods of administration thereof
HRP20240586T1 (hr) * 2018-10-09 2024-07-19 The University Of British Columbia Sastavi i sustavi koji sadrže transfekcijske sposobne vezikle bez organskih otapala i deterdženta i s njim povezanim postupcima
KR20210133218A (ko) * 2019-01-31 2021-11-05 모더나티엑스, 인크. 볼텍스 믹서 및 연계된 방법, 시스템 및 이의 장치
KR102732019B1 (ko) * 2019-04-15 2024-11-20 글로벌 라이프 사이언시즈 솔루션즈 캐나다 유엘씨 T 세포 유전자 발현의 비바이러스 변형
ES2973521T3 (es) 2019-06-20 2024-06-20 Prec Nanosystems Ulc Lípidos ionizables para la administración de ácidos nucleicos
AU2020350759A1 (en) 2019-09-19 2022-03-31 Modernatx, Inc. Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
CA3155015A1 (en) 2019-09-19 2021-03-25 Modernatx, Inc. Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
CN115778904B (zh) * 2019-10-29 2025-03-28 珠海丽凡达生物技术有限公司 一种用于体外转染和体内递送mRNA的制剂
CA3169669A1 (en) 2020-01-31 2021-08-05 Modernatx, Inc. Methods of preparing lipid nanoparticles
IL297419B2 (en) 2020-04-22 2025-02-01 BioNTech SE Coronavirus vaccine
EP3915544A1 (en) * 2020-05-25 2021-12-01 Leon-Nanodrugs GmbH Method for producing a liposome dispersion
GB202011367D0 (en) * 2020-07-22 2020-09-02 Micropore Tech Limited Method of preparing liposomes
EP4192432A1 (en) 2020-08-06 2023-06-14 ModernaTX, Inc. Methods of preparing lipid nanoparticles
MA71659A (fr) 2020-08-06 2025-05-30 Modernatx, Inc. Compositions pour l'administration de molécules de charge utile à l'épithélium des voies respiratoires
US11406703B2 (en) 2020-08-25 2022-08-09 Modernatx, Inc. Human cytomegalovirus vaccine
WO2022104131A1 (en) 2020-11-13 2022-05-19 Modernatx, Inc. Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
DE102020214601A1 (de) 2020-11-19 2022-05-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Verfahren und Vorrichtung zur Herstellung einer Flüssigkeit enthaltend Liposomen und hergestellte Flüssigkeit
US11524023B2 (en) 2021-02-19 2022-12-13 Modernatx, Inc. Lipid nanoparticle compositions and methods of formulating the same
EP4346901A4 (en) * 2021-06-01 2025-04-23 The University of British Columbia MRNA DELIVERY USING LIPID NANOPARTICLES
WO2023009422A1 (en) 2021-07-26 2023-02-02 Modernatx, Inc. Processes for preparing lipid nanoparticle compositions for the delivery of payload molecules to airway epithelium
WO2023009421A1 (en) 2021-07-26 2023-02-02 Modernatx, Inc. Processes for preparing lipid nanoparticle compositions
CN115671294A (zh) * 2021-07-27 2023-02-03 中国医学科学院基础医学研究所 St类脂质化合物在制备核酸递送试剂中的应用及相关产品
EP4379055A4 (en) 2021-07-27 2025-08-06 Sk Bioscience Co Ltd MRNA FOR PROTEIN EXPRESSION AND TEMPLATE FOR IT
WO2023076598A1 (en) 2021-10-29 2023-05-04 Modernatx, Inc. Lipid amines
CN118829423A (zh) 2021-11-12 2024-10-22 摩登纳特斯有限公司 用于将有效载荷分子递送至气道上皮的组合物
US12186387B2 (en) 2021-11-29 2025-01-07 BioNTech SE Coronavirus vaccine
EP4475882A1 (en) 2022-02-09 2024-12-18 ModernaTX, Inc. Mucosal administration methods and formulations
WO2023190170A1 (ja) * 2022-03-28 2023-10-05 日油株式会社 核酸内封脂質ナノ粒子の製造方法及びこれを含む医薬品組成物の製造方法、並びに、核酸を細胞内又は標的細胞内に導入する方法
WO2024002985A1 (en) 2022-06-26 2024-01-04 BioNTech SE Coronavirus vaccine
IT202200016386A1 (it) * 2022-08-02 2024-02-02 Univ Degli Studi Roma La Sapienza Nanoparticelle lipidiche multicomponenti ad elevata fusogenicità cellulare per la veicolazione di acidi nucleici e relativo processo di preparazione
WO2024197404A1 (en) * 2023-03-30 2024-10-03 Ho Emmanuel Abraham Bacteria-responsive particles, methods for preparation, and use in packaging or on surfaces
AU2024279278A1 (en) 2023-05-31 2025-12-18 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
CN117070570A (zh) * 2023-08-28 2023-11-17 南通大学 提高脂质体转染试剂的转染效率的方法
EP4516295A1 (en) * 2023-09-04 2025-03-05 ETH Zurich Ph-inducible structure-switching lipid nanovectors, semi-synthetic extracellular vesicles, methods of making same and uses thereof
WO2025063214A1 (ja) * 2023-09-22 2025-03-27 国立大学法人東北大学 核酸を内封したリガンド修飾脂質ナノ粒子の製造方法

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7422902B1 (en) 1995-06-07 2008-09-09 The University Of British Columbia Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5981501A (en) 1995-06-07 1999-11-09 Inex Pharmaceuticals Corp. Methods for encapsulating plasmids in lipid bilayers
CN1173776C (zh) 1996-06-28 2004-11-03 卡钳技术有限公司 在微规模流体性设备里的高通过量的筛选分析系统
EP1030733A4 (en) 1997-02-05 2000-08-30 California Inst Of Techn Microfluidic sub-millisecond mixers
AU733310C (en) 1997-05-14 2001-11-29 University Of British Columbia, The High efficiency encapsulation of charged therapeutic agents in lipid vesicles
US6835395B1 (en) 1997-05-14 2004-12-28 The University Of British Columbia Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
WO2000029103A1 (en) 1998-11-13 2000-05-25 Optime Therapeutics, Inc. Method and apparatus for liposome production
EP1203614A1 (de) 2000-11-03 2002-05-08 Polymun Scientific Immunbiologische Forschung GmbH Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln
US8137699B2 (en) 2002-03-29 2012-03-20 Trustees Of Princeton University Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
WO2002087541A1 (en) * 2001-04-30 2002-11-07 Protiva Biotherapeutics Inc. Lipid-based formulations for gene transfer
EP1412065A2 (en) 2001-07-27 2004-04-28 President And Fellows Of Harvard College Laminar mixing apparatus and methods
US7252928B1 (en) 2002-03-12 2007-08-07 Caliper Life Sciences, Inc. Methods for prevention of surface adsorption of biological materials to capillary walls in microchannels
US7901939B2 (en) 2002-05-09 2011-03-08 University Of Chicago Method for performing crystallization and reactions in pressure-driven fluid plugs
WO2003097805A2 (en) 2002-05-15 2003-11-27 California Pacific Medical Center Delivery of nucleic acid-like compounds
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
JP2006507921A (ja) 2002-06-28 2006-03-09 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 流体分散のための方法および装置
US7214348B2 (en) 2002-07-26 2007-05-08 Applera Corporation Microfluidic size-exclusion devices, systems, and methods
MXPA05010499A (es) 2003-03-31 2006-05-25 Johnson & Johnson Particulas lipidicas que tienen un revestimiento lipidico asimetrico y metodo de preparacion de las mismas.
US7160025B2 (en) 2003-06-11 2007-01-09 Agency For Science, Technology And Research Micromixer apparatus and methods of using same
EP1668355A4 (en) 2003-08-28 2011-11-09 Celula Inc METHODS AND APPARATUS FOR SORTING CELLS USING AN OPTICAL SWITCH IN A MICROFLUIDIC CHANNEL NETWORK
EP1664316B1 (en) 2003-09-15 2012-08-29 Protiva Biotherapeutics Inc. Polyethyleneglycol-modified lipid compounds and uses thereof
US20050175683A1 (en) 2003-10-24 2005-08-11 Yuanpeng Zhang Preparation of lipid particles
EP1537858A1 (en) 2003-12-04 2005-06-08 Vectron Therapeutics AG Drug delivery vehicles and uses thereof
US7507380B2 (en) 2004-03-19 2009-03-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Microchemical nanofactories
EP1750673B1 (en) 2004-05-17 2009-12-02 Tekmira Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
JP4764426B2 (ja) 2004-06-07 2011-09-07 プロチバ バイオセラピューティクス インコーポレイティッド カチオン性脂質および使用方法
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
WO2006027787A1 (en) 2004-09-09 2006-03-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal compositions of glucocorticoid and glucocorticoid derivatives
EP1804964A1 (en) 2004-10-01 2007-07-11 Velocys Inc. Multiphase mixing process using microchannel process technology
EP1679115A1 (en) 2005-01-07 2006-07-12 Corning Incorporated High performance microreactor
AU2006226744B2 (en) 2005-03-23 2012-02-23 Velocys, Inc. Surface features in microprocess technology
US20060219307A1 (en) 2005-03-31 2006-10-05 National Taiwan University Micromixer apparatus and method therefor
CN101267805A (zh) 2005-07-27 2008-09-17 普洛体维生物治疗公司 制造脂质体的系统和方法
CA2623531C (en) 2005-10-07 2013-12-10 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Matrix metalloproteinase 11 vaccine
US20070087045A1 (en) * 2005-10-14 2007-04-19 Industrial Technology Research Institute Lipid carrier and method of preparing the same
JP2007252979A (ja) 2006-03-20 2007-10-04 National Institute Of Advanced Industrial & Technology マイクロリアクタによる化合物の製造方法、そのマイクロリアクタ、及びマイクロリアクタ用の分流器
US7794136B2 (en) 2006-05-09 2010-09-14 National Tsing Hua University Twin-vortex micromixer for enforced mass exchange
WO2007150030A2 (en) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
WO2008053988A1 (fr) 2006-11-02 2008-05-08 National University Corporation Nagoya University Procédé de production de microcapsules
CN101209243B (zh) 2006-12-29 2010-12-08 石药集团中奇制药技术(石家庄)有限公司 一种脂质体药物及其制备方法
CN101765423B (zh) 2007-05-31 2014-08-06 安特里奥公司 核酸纳米粒子和其用途
EP2167233B1 (en) 2007-06-26 2013-01-23 Micronit Microfluidics B.V. Device and method for fluidic coupling of fluidic conduits to a microfluidic chip, and uncoupling thereof
WO2009086558A1 (en) 2008-01-02 2009-07-09 Tekmira Pharmaceuticals Corporation Improved compositions and methods for the delivery of nucleic acids
US8414182B2 (en) 2008-03-28 2013-04-09 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Micromixers for nanomaterial production
CA2721333C (en) 2008-04-15 2020-12-01 Protiva Biotherapeutics, Inc. Novel lipid formulations for nucleic acid delivery
US8187554B2 (en) 2008-04-23 2012-05-29 Microfluidics International Corporation Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems
WO2010012005A2 (en) 2008-07-25 2010-01-28 S.K. Pharmaceuticals, Inc. Methods and systems for production of nanoparticles
CN111808084A (zh) 2008-11-10 2020-10-23 阿布特斯生物制药公司 用于递送治疗剂的新型脂质和组合物
EP3243504A1 (en) * 2009-01-29 2017-11-15 Arbutus Biopharma Corporation Improved lipid formulation
KR101766408B1 (ko) * 2009-06-10 2017-08-10 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
AP2015008874A0 (en) * 2009-08-14 2015-11-30 Alnylam Pharmaceuticals Inc Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
CA2781527C (en) 2009-09-23 2017-10-24 Indu Javeri Methods for the preparation of liposomes
CN107028886A (zh) * 2009-11-04 2017-08-11 不列颠哥伦比亚大学 含有核酸的脂质粒子及相关的方法
US9006417B2 (en) 2010-06-30 2015-04-14 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
WO2012016184A2 (en) 2010-07-30 2012-02-02 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
US8361415B2 (en) 2010-09-13 2013-01-29 The Regents Of The University Of California Inertial particle focusing system

Similar Documents

Publication Publication Date Title
JP2016515815A5 (https=)
JP7753190B2 (ja) 核酸の送達のための改善された脂質ナノ粒子
CN114746401B (zh) 用于核酸递送的可离子化脂质
CN112996519B (zh) 用于核酸的器官特异性递送的组合物和方法
JP6605446B2 (ja) 形質移入用の脂質ナノ粒子および関連方法
JP2016028031A5 (https=)
Yang et al. A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia
CN120360966A (zh) 用于核酸的器官特异性递送的组合物和方法
JP2013510096A5 (https=)
CN103153347A (zh) 用于寡核苷酸递送的新型低分子量阳离子脂质
CN115297850A (zh) 用于肝纤维化和其他与纤维化相关的疾病的基于外排体的治疗
US20250345284A1 (en) Lipid nanoparticle (lnp) compositions and methods of use thereof
US20070054873A1 (en) Glucocorticoid modulation of nucleic acid-mediated immune stimulation
CN121443279A (zh) 用于细胞疗法的脂质纳米颗粒制剂和相关方法
JP2025528441A (ja) 核酸を含む活性剤の送達のための組成物及び方法
EP4519243A2 (en) Siloxane-based lipids, lipid nanoparticle compositions comprising the same, and methods of use thereof for targeted delivery
Luo Development of Lipid-like Nanoparticles for mRNA Delivery
WO2025072150A1 (en) Zwitterionic lipid nanoparticle compositions, and methods of use
JP2025516241A (ja) ピコルナウイルスをコードするrnaポリヌクレオチドの製造
KR20250029907A (ko) 백신용 지질 나노입자 제제
HK40055120B (zh) 用於核酸的器官特异性递送的组合物和方法
Yung Nanoparticle Drug Delivery Systems for Cancer Therapy
HK40055907A (en) Compositions and methods for organ specific delivery of nucleic acids